FIELD: molecular biology, biochemistry, medicine, oncology.
SUBSTANCE: invention relates to DNA sequences found in analysis of mDNA from squamous carcinoma cellular lines of different origin wherein these DNA sequences represent transcripts from rearranged genes SCCA1 and SCCA2. Result of rearrangement is formation of fused gene consisting of exon 2-7 of gene SCCA1 and exon 8 of gene SCCA2, or exons 2-7 of gene SCCA2 and exon 8 of gene SCCA1. Prepared expressing vectors comprising above said combinations of exons of two genes provide synthesis of corresponding fused protein in host-cell. Proposed sequences of nucleic acids and genetic constructions based on thereof represent novel agents for diagnosis squamous carcinomas.
EFFECT: valuable biological and medicinal properties of transcripts.
8 cl, 9 dwg, 1 tbl, 5 ex
Title | Year | Author | Number |
---|---|---|---|
NEW CYTOKINE ZALPHA 11-LIGAND | 2000 |
|
RU2258710C2 |
UNIVERSAL INTEGRATION VECTOR SB7G_HIGH AND RECOMBINANT PLASMID SB7G_HIGH_DEV_57, PROVIDING SYNTHESIS AND SECRETION OF RECOMBINANT HUMAN ANTIBODY TO RECEPTOR-BINDING DOMAIN (RBD) OF CORONAVIRUS SARS-CoV-2 IN MAMMALIAN CELLS AND OBTAINED USING UNIVERSAL VECTOR SB7G_HIGH, AND RECOMBINANT MONOCLONAL ANTIBODY DEV_K57, HAVING VIRUS-NEUTRALIZING ACTIVITY ON SARS-CoV-2 | 2023 |
|
RU2829359C1 |
SILENT ANTI-CD28-ANTIBODY AND THEIR APPLYING | 2001 |
|
RU2261723C2 |
ANTIBODY FRAGMENTS SPECIFIC IN RELATION TO HUMAN CANCER-EMBRYONIC ANTIGEN (CEA) | 2003 |
|
RU2294939C2 |
METHOD OF DETECTION OF MICROORGANISMS BELONGING TO SPECIES OF MYCOPLASMA PNEUMONIAE MIND AND/OR MYCOPLASMA GENITALIUM | 2010 |
|
RU2575075C2 |
POLYPEPTIDE WITH PHOSPHODIESTERASE ENZYMATIC ACTIVITY | 1998 |
|
RU2272841C2 |
ANTIBODY DIRECTED ON SIGLEC-15 PROTEIN, BOUND WITH OSTEOCLASTS | 2008 |
|
RU2475499C2 |
METHOD FOR PANCREATIC CANCER DETECTION | 2012 |
|
RU2624040C2 |
ANTIBODY VFF-18 AND ITS ANALOGUES | 1995 |
|
RU2204606C2 |
RECOMBINANT DNA MOLECULE ENCODING OF MODIFIED SWINE FACTOR VIII (POL1212), EXPRESSION VECTORS, MODIFIED SWINE FACTOR VIII, THERAPEUTIC COMPOSITION, METHODS FOR PRODUCTION OF MODIFIED SWINE FACTOR VIII PROTEIN (VARIANTS) AND CELL LINES (VARIANTS) | 2001 |
|
RU2285724C2 |
Authors
Dates
2006-11-27—Published
2002-03-15—Filed